Expression Vectors Market – Growth, Future Prospects & Competitive Analysis, 2018-2026

Market Insights

Expression vectors are the cloning vectors that possess suitable expression signals to provide the highest gene expression. Expression vectors usually aid in presenting a gene of interest in a targeted cell, which further catalyzes the mechanism of the cell to create a protein encoded by the gene. Expression vectors are applied for the manufacturing of therapeutic agents, constantly activated proteins for biophysical, biochemical, and structural studies, and huge capacities of proteins for industrial applications. Expression vectors are also used for the manufacturing of enzymes, insulin, antibiotics, vaccines, growth hormones, and antibodies. The expression vectors market is steadily growing, owing to rising demand for protein-based drugs, rising prevalence of lifestyle, genetic, and infectious disorders, and increased R&D activities due to increased investment in protein therapy. The key factors restraining the market growth are increasing market consolidation, stringent regulatory policies assisting market entry barriers, and the huge cost of protein therapy.

Bacterial expression vectors are observed as the largest market segment due to the high rate of transformation and organized transformation protocols. During the forecast period of 2018–2026, the mammalian expression vectors segment was observed as the fastest-growing market due to the mammalian host system’s capability to perform processes of recombinant proteins, folding, and multifaceted post-translational alterations. The pharmaceutical industry was observed as the largest end-user market due to rising demand for biological treatments, especially against chronic disease, and rising research and development activities for novel drug therapies.

North America was observed as the largest expression vectors market due to key market drivers such as incessant progress in research and development of novel therapeutics, rising demand for efficient and safe drug therapies, and the rising prevalence of chronic diseases coupled with public awareness. Asia Pacific will grow at the fastest CAGR between 2018 and 2026, owing to rapid growth in the pharmaceutical and biotechnology industries, rising research and development infrastructure in the healthcare industry, and rising demand for effective drugs in the treatment of chronic diseases.

The expression vector market is divided into the following categories:

Host

• Bacterial expression vectors
• E. coli expression vectors
• Other Bacterial Expression Vectors

Insect expression vectors

• Baculovirus Expression Vectors
• Other insect expression vectors
• Mammalian Expression Vectors
• CHO expression vectors
• Other mammalian expression vectors

Yeast Expression Vectors

• K. lactis expression vectors
• Pichia pastoris expression vectors
• Saccharomyces cerevisiae expression vectors
• Other Yeast Expression Vectors

End User

• Pharmaceutical and Biotechnology Industry
• Contract Research Organizations and Contract Manufacturing Organizations
• Academic Research Institutes

Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Key players identified for the expression vectors market include:

Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Promega Corporation, Bio-Rad Laboratories, New England Biolabs, Life Technologies Corporation, Clontech Laboratories, Inc., Merck Millipore, QIAGEN, and GenScript USA, Inc.

This report offers:

• The market assessment is done by furnishing the market size and compounded annual growth rate, considering 2017 as the base year and the period from 2018 to 2026 as the forecast period.
• For the geography, host, and end-user segments, an attractive investment proposition is given, which helps expression vector manufacturers contemplate useful financial decisions.
• The competitive landscape helps in determining the competitive milieu currently existing in the expression vector market.
• The financial health of leading players is considered in the financial information segment, and a diverse range of expression vectors is covered in the product portfolio section. Recent news coverage keeps us informed regarding the latest strategic developments and their impact on the expression vector market.